Medical devices, healthcare technology and the business of care
510(k) clearance · K260648

PolySense

Itamar Medical , Ltd. · Decision date Oct 30, 2026

MEDTECHLEDGER EXPLANATIONK260648

What did the FDA decide?

FDA recorded a substantially equivalent decision for PolySense, a 510(k) submitted by Itamar Medical, Ltd. of Caesarea, Israel, under number K260648. The decision date is 30 October 2026, and the application was received 27 February 2026. The device falls under regulation 882.1835 with classification product code GWL and subsequent product code DSH; the regulation medical specialty and review panel are both listed as Neurology. The record describes the submission type as Traditional, with no third-party review, no combination product designation and no authorized predetermined change control plan.

Substantially equivalent in this 510(k) context denotes marketing clearance rather than premarket approval. The public record identifies the device classification name as Amplifier, Physiological Signal, but does not describe the specific components, design changes or performance data supporting the equivalence determination. The corresponding FDA summary document is not included in the available material, so the basis for the decision and any comparison device remain unknown.

Regulatory pathway
510(k) premarket notification
Clinical specialty
Neurology
Decision date
Oct 30, 2026

FDA source record · MedtechLedger’s explanation describes the recorded change.

Regulatory record facts

Identifier
K260648
Regulatory pathway
510(k) premarket notification
Product code
GWL
Decision code
SESE
Decision date
Oct 30, 2026
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: Amplifier, Physiological Signal.

Product code
GWL
FDA device class
2

FDA decision timeline

  1. K260648 received

    Application receipt date recorded by FDA.

  2. K260648 · FDA decision

    SESE

Related devices and submissions

Explore the linked device profile

No additional submissions with a verified PMA or product-code relationship are linked here.

Regulatory context

A 510(k) submission seeks a finding of substantial equivalence to a legally marketed device. A clearance and a PMA approval are different regulatory decisions.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

Itamar Medical , Ltd.

Headquarters
Not reported
Brand website
Not reported
FDA applicant address
Caesarea

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records